NEIRG
ABBV icon

New England Investment & Retirement Group’s AbbVie ABBV Stock Holding History

New England Investment & Retirement Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5.91M Sell
54,775
-696
-1% -$79.5K 1.36% 28
2021
Q2 		$6.25M Buy
55,471
+4,277
+8% +$482K 1.36% 28
2021
Q1 		$5.54M Buy
51,194
+503
+1% +$53.8K 1.34% 25
2020
Q4 		$5.43M Sell
50,691
-416
-0.8% -$40K 1.27% 28
2020
Q3 		$4.48M Sell
51,107
-840
-2% -$79.1K 1.13% 28
2020
Q2 		$5.1M Buy
51,947
+51,747
+25,874% +$4.56M 1.28% 25
2020
Q1 		$15K Buy
+200
New +$17K 0.01% 128

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

New England Investment & Retirement Group's ABBV Position: Q3 2021 in Review

New England Investment & Retirement Group reduced its AbbVie (ABBV) stake by 1.3% in Q3 2021, selling an estimated $79.5K and leaving 54,775 shares worth $5.91M. The position accounts for 1.36% of the portfolio, ranked #28.

New England Investment & Retirement Group first reported a position in ABBV in Q1 2020 and has held it in 7 quarters since. The position peaked at $6.25M in Q2 2021. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • New England Investment & Retirement Group held 54,775 shares of AbbVie worth $5.91M as of Q3 2021.
  • New England Investment & Retirement Group sold 696 AbbVie shares in Q3 2021, an estimated $79.5K.
  • AbbVie made up 1.36% of New England Investment & Retirement Group's portfolio in Q3 2021, its #28 holding.
  • New England Investment & Retirement Group first reported a position in AbbVie in Q1 2020 and has held it in 7 quarters since.
  • New England Investment & Retirement Group's AbbVie position peaked at $6.25M in Q2 2021.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on New England Investment & Retirement Group's 13F filing for Q3 2021, filed 28 Oct 2021.